KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Accounts Payables (2018 - 2026)

Castle Biosciences' Accounts Payables history spans 8 years, with the latest figure at $18.7 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 171.13% to $18.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.7 million, a 171.13% increase, with the full-year FY2025 number at $18.7 million, up 171.13% from a year prior.
  • Accounts Payables hit $18.7 million in Q4 2025 for Castle Biosciences, up from $12.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for CSTL hit a ceiling of $18.7 million in Q4 2025 and a floor of $1.4 million in Q2 2021.
  • Historically, Accounts Payables has averaged $7.3 million across 5 years, with a median of $6.9 million in 2023.
  • Biggest five-year swings in Accounts Payables: crashed 45.17% in 2021 and later soared 200.57% in 2023.
  • Tracing CSTL's Accounts Payables over 5 years: stood at $2.5 million in 2021, then soared by 85.82% to $4.7 million in 2022, then skyrocketed by 117.04% to $10.3 million in 2023, then crashed by 32.79% to $6.9 million in 2024, then surged by 171.13% to $18.7 million in 2025.
  • Business Quant data shows Accounts Payables for CSTL at $18.7 million in Q4 2025, $12.2 million in Q3 2025, and $13.2 million in Q2 2025.